Randy Hubbell
Chief Executive Officer bij Carmell Regen Med Corp.
Vermogen: 5 748 $ op 30-04-2024
Profiel
Randy Hubbell is currently the President, Chief Executive Officer & Director at Carmell Regen Med Corp.
and also a Director at Neuraptive Therapeutics, Inc. He previously worked as the President, Chief Executive Officer & Director at Carmell Corp., Executive Director-Sales & Marketing at Vasca, Inc., Executive Director-Strategic Alliances at Cordis Cardiology, Principal at International Business Machines Corp., Principal at Johnson & Johnson, Principal at Boston Scientific Corp., Principal at Enmedia, Inc., Chief Commercial Officer at Cardiva Medical, Inc., Vice President-Global Strategic Marketing at Johnson & Johnson Pharmaceutical Group, and Vice President-Global Strategic Marketing at Ethicon Biosurgery Ireland.
Mr. Hubbell holds an MBA degree from Loyola University New Orleans and an undergraduate degree from Tulane University (Louisiana).
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 28-08-2023 | 2 750 ( 0.01% ) | 5 748 $ | 30-04-2024 |
Actieve functies van Randy Hubbell
| Bedrijven | Functie | Begin |
|---|---|---|
Carmell Regen Med Corp.
 Carmell Regen Med Corp. Pharmaceuticals: OtherHealth Technology Carmell Regen Med Corp. develops biomaterials manufactured from blood plasma. It offers biologically-active plastics from blood plasma for treating injuries to bone and connective tissue. The firm focuses on products for the sports medicine market with devices for the repair of tendon and cartilage injuries. It provides REPAIR Bone Putty, a putty form of the plasma-based plastics to fill bone defects; and surgical scaffold for soft tissue repair that heals injured tendons and ligaments. The company was founded by James Edward Burgess, Phil Campbell, and Lee E. Weiss in 2007 and is headquartered in Pittsburgh, PA. | Chief Executive Officer | 16-02-2016 |
Neuraptive Therapeutics, Inc.
 Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | Director/Board Member | - |
Eerdere bekende functies van Randy Hubbell
| Bedrijven | Functie | Einde |
|---|---|---|
| CARMELL CORPORATION | Chief Executive Officer | 31-08-2023 |
Vasca, Inc.
 Vasca, Inc. Medical SpecialtiesHealth Technology Vasca, Inc. develops access and related technologies. It manufactures and markets life site hemodialysis access system technologies to improve the quality of patient care in the United States. The company was founded by Jeffrey H. Burbank in April 1996 and is headquartered in Tewksbury, MA. | Sales & Marketing | 01-01-2000 |
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | 01-01-1998 |
| IBM | Corporate Officer/Principal | 01-01-1993 |
| Enmedia, Inc. | Corporate Officer/Principal | - |
Opleiding van Randy Hubbell
| Loyola University New Orleans | Masters Business Admin |
| Tulane University (Louisiana) | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| IBM | Technology Services |
| JOHNSON & JOHNSON | Health Technology |
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| Bedrijven in privébezit | 9 |
|---|---|
Vasca, Inc.
Vasca, Inc. Medical SpecialtiesHealth Technology Vasca, Inc. develops access and related technologies. It manufactures and markets life site hemodialysis access system technologies to improve the quality of patient care in the United States. The company was founded by Jeffrey H. Burbank in April 1996 and is headquartered in Tewksbury, MA. | Health Technology |
| Enmedia, Inc. | |
Cardiva Medical, Inc.
 Cardiva Medical, Inc. Medical SpecialtiesHealth Technology Cardiva Medical, Inc. designs and develops vascular access management products. It offers VASCADE, an extravascular closure device designed to increase the comfort and safety of vascular closure for patients; and Catalyst, a device that supports the body's natural healing process by enhancing the vessel's inherent natural elastic recoil, tissue apposition and coagulation. The company was founded by Zia Yassinzadeh and Augustine Y. Lien in July 2002 and is headquartered in Santa Clara, CA. | Health Technology |
Cordis Cardiology
 Cordis Cardiology Miscellaneous Commercial ServicesCommercial Services Part of Cardinal Health, Inc., Cordis Cardiology engages in development and manufacturing of interventional cardiovascular and endovascular technologies. The private company is based in Miami Lakes, FL. The CEO of the company is Shar Matin. | Commercial Services |
Carmell Regen Med Corp.
Carmell Regen Med Corp. Pharmaceuticals: OtherHealth Technology Carmell Regen Med Corp. develops biomaterials manufactured from blood plasma. It offers biologically-active plastics from blood plasma for treating injuries to bone and connective tissue. The firm focuses on products for the sports medicine market with devices for the repair of tendon and cartilage injuries. It provides REPAIR Bone Putty, a putty form of the plasma-based plastics to fill bone defects; and surgical scaffold for soft tissue repair that heals injured tendons and ligaments. The company was founded by James Edward Burgess, Phil Campbell, and Lee E. Weiss in 2007 and is headquartered in Pittsburgh, PA. | Health Technology |
| Johnson & Johnson Pharmaceutical Group | |
| Ethicon Biosurgery Ireland | |
Neuraptive Therapeutics, Inc.
Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | Health Technology |
| Carmell Therapeutics Corp. |
